Table 2 Characteristics of IgAV patients with and without gastrointestinal or renal involvement
From: Predicting gastrointestinal and renal involvement in adult IgA vasculitis
Characteristics | Gastrointestinal involvement | Renal involvement | ||||
|---|---|---|---|---|---|---|
Yes | No | p value | Yes | No | p value | |
Number | 58 | 156 | 83 | 131 | ||
Disease duration (days)# | 8 (7–15) | 7 (5–21) | 0.650 | 7 (5–19) | 7 (5–21) | 0.682 |
Age (years)# | 55.5 (39.0–74.0) | 65.4 (48.1–76.9) | 0.053 | 67.8 (53.6–77.4) | 59.5 (40.2–75.8) | 0.006 |
Male gender* | 70.7 | 55.1 | 0.043 | 61.4 | 58.0 | 0.669 |
Active smoking* | 22.4 | 18.6 | 0.563 | 26.5 | 15.3 | 0.052 |
Prior infection* | 34.5 | 31.4 | 0.743 | 32.5 | 32.1 | 1.0 |
Concurrent infection* | 10.3 | 17.3 | 0.287 | 16.9 | 14.5 | 0.699 |
New medication* | 25.9 | 23.7 | 0.724 | 24.1 | 24.4 | 1.0 |
Past cancer* | 6.9 | 14.7 | 0.165 | 12.0 | 13.0 | 1.0 |
Generalized purpura* | 79.3 | 40.4 | < 0.001 | 60.2 | 45.0 | 0.036 |
Necrotic purpura* | 46.6 | 45.5 | 1.0 | 48.2 | 44.3 | 0.673 |
Elevated serum IgA* | 34.5 | 52.6 | 0.021 | 60.2 | 39.7 | 0.005 |
NLR# | 4.89 (3.3–6.7) | 3.8 (2.4–5.5) | 0.003 | 4.6 (2.9–6.5) | 3.8 (2.4–5.5) | 0.041 |